(Q36120838)

12 August 2017

1 reference

title

HIV resistance testing in the USA--a model for the application of pharmacogenomics in the clinical setting (English)

1 reference

12 August 2017

1 reference

Ronald A Blum

1

1 reference

12 August 2017

Neil Wylie

series ordinal

2

1 reference

12 August 2017

Tom England

series ordinal

3

1 reference

12 August 2017

Cynthia French

series ordinal

4

1 reference

12 August 2017

publication date

1 March 2005

1 reference

12 August 2017

1 reference

12 August 2017

volume

6

1 reference

12 August 2017

issue

2

1 reference

12 August 2017

page(s)

169-179

1 reference

HIV pharmacogenomics: closer to personalized therapy?

12 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14622416.6.2.169

Pharmacogenetics: the new science of personalizing treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.6.2.169

Fine-tuning pharmacogenetics: paradigm for linking laboratory results to clinical action

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.6.2.169

The thiopurine S-methyltransferase gene locus -- implications for clinical pharmacogenomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.6.2.169

Hepatitis C virus genotyping: clinical implications and methods

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.6.2.169

Antiretroviral drug resistance testing in adults infected with human immunodeficiency virus type 1: 2003 recommendations of an International AIDS Society-USA Panel

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.6.2.169

Use of genotypic resistance testing to guide hiv therapy: clinical impact and cost-effectiveness

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.6.2.169

The influence of HLA genotype on AIDS

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.6.2.169

Association between presence of HLA-B*5701, HLA-DR7, and HLA-DQ3 and hypersensitivity to HIV-1 reverse-transcriptase inhibitor abacavir

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.6.2.169

Impact of host genetics on HIV disease progression and treatment: new conflicts on an ancient battleground

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.6.2.169

Population biology of HIV-1 infection: viral and CD4+ T cell demographics and dynamics in lymphatic tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.6.2.169

HIV-1 dynamics in vivo: virion clearance rate, infected cell life-span, and viral generation time

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.6.2.169

Evolution of phenotypic drug susceptibility and viral replication capacity during long-term virologic failure of protease inhibitor therapy in human immunodeficiency virus-infected adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.6.2.169

The prevalence of antiretroviral drug resistance in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.6.2.169

Antiretroviral treatment for adult HIV infection in 2002: updated recommendations of the International AIDS Society-USA Panel.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.6.2.169

Clinical and laboratory guidelines for the use of HIV-1 drug resistance testing as part of treatment management: recommendations for the European setting. The EuroGUidelines Group for HIV resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.6.2.169

British HIV Association (BHIVA) guidelines for the treatment of HIV-infected adults with antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.6.2.169

HIVbase: a PC/Windows-based software offering storage and querying power for locally held HIV-1 genetic, experimental and clinical data

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.6.2.169

Positive selection detection in 40,000 human immunodeficiency virus (HIV) type 1 sequences automatically identifies drug resistance and positive fitness mutations in HIV protease and reverse transcriptase

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.6.2.169

Clustered mutations in HIV-1 gag are consistently required for escape from HLA-B27-restricted cytotoxic T lymphocyte responses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.6.2.169

Favorable and unfavorable HLA class I alleles and haplotypes in Zambians predominantly infected with clade C human immunodeficiency virus type 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.6.2.169

Host genetic profiles predict virological and immunological control of HIV-1 infection in adolescents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.6.2.169

HLA and HIV-1: heterozygote advantage and B*35-Cw*04 disadvantage

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.6.2.169

Genetics of HIV-1 infection: chemokine receptor CCR5 polymorphism and its consequences.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.6.2.169

Modulating influence on HIV/AIDS by interacting RANTES gene variants

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.6.2.169

The effect of genetic variation in chemokines and their receptors on HIV transmission and progression to AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.6.2.169

HIV-1 infection and AIDS dementia are influenced by a mutant MCP-1 allele linked to increased monocyte infiltration of tissues and MCP-1 levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.6.2.169

Genetic restriction of HIV-1 pathogenesis to AIDS by promoter alleles of IL10.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.6.2.169

21 January 2018

Identifiers

DOI

10.1517/14622416.6.2.169

1 reference

12 August 2017

1 reference